Literature DB >> 8044522

Immunological parameters in peripheral blood of patients with renal cell carcinoma before and after nephrectomy.

G Dadian1, P G Riches, D C Henderson, A Taylor, J Moore, H Atkinson, M E Gore.   

Abstract

OBJECTIVE: To determine the effects of nephrectomy on the immune response of patients with renal cell carcinoma (RCC). PATIENTS AND METHODS: Five patients with RCC were monitored before and over a period of up to 3 months after nephrectomy. The aspects measured were the phenotypic expression of markers on circulating lymphocytes, circulating concentrations of cytokines, markers of inflammatory and immune responses, and natural killer (NK) cell and lymphokine-activated killer (LAK) cell activity in peripheral blood mononuclear cells (PBMC). The suppressive activity of patients' plasma on NK activity and ability to generate interleukin-2 (IL-2) induced LAK cells in PBMC of normal volunteers was also investigated.
RESULTS: The results indicated that high CD4/8 ratios were present pre-nephrectomy with evidence of inflammatory responses and immune activation in some patients, particularly those with metastatic disease.
CONCLUSION: The effect of nephrectomy was to decrease the inflammatory response and increase immune activation. Various defects in NK cell activity and LAK cell generation were demonstrated pre-surgery which slowly improved once the primary tumour had been removed and it is suggested that such defects could have contributed to tumour growth and development due to an ineffective immune response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8044522     DOI: 10.1111/j.1464-410x.1994.tb16538.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  5 in total

Review 1.  The Role of Nephrectomy for Kidney Cancer in the Era of Targeted and Immune Therapies.

Authors:  Ulka N Vaishampayan
Journal:  Am Soc Clin Oncol Educ Book       Date:  2016

Review 2.  Lymphocyte subsets as prognostic markers for cancer patients receiving immunomodulative therapy.

Authors:  M Hernberg
Journal:  Med Oncol       Date:  1999-09       Impact factor: 3.064

Review 3.  Surgery for metastatic renal cell cancer.

Authors:  Shomik Sengupta; Bradley C Leibovich; Michael L Blute; Horst Zincke
Journal:  World J Urol       Date:  2005-06-30       Impact factor: 4.226

4.  "PROBE"ing the Role of Cytoreductive Nephrectomy in Advanced Renal Cancer.

Authors:  Hannah Bell; Brittney H Cotta; Simpa S Salami; Hyung Kim; Ulka Vaishampayan
Journal:  Kidney Cancer J       Date:  2022-03-15

Review 5.  Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature.

Authors:  Scott J Dawsey; Steven C Campbell; Moshe C Ornstein
Journal:  Curr Oncol       Date:  2021-05-20       Impact factor: 3.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.